Institute of Bioorganic Chemistry

http://iboch.bas-net.by/  

The method of personalization of drug treatment in psychiatry using the results of pharmacogenetic testing

COUNTRY OF ORIGIN

IDENTIFIER

BO3911

PUBLISHED

2021-05-21

LAST UPDATE

2021-05-21

DEADLINE

Linked profile in other language
Responsible
Aleksej Yantsevich
+375 17 357 8761
info@iboch.by
Summary
The Institute of Bioorganic Chemistry offers consumers a method of personalizing drug treatment in psychiatry using the results of pharmacogenetic testing as part of an outsourcing agreement is looking for partners to conclude a distribution service agreement.
Description
The method of personalizing the treatment of mental and behavioral disorders using an automated information system for the clinical interpretation of the results of pharmacogenetic testing allows, based on the patient's genetic data, to sel ect the appropriate drug and its optimal dosage regimen (introduced into practical healthcare). The method is validated on the Belarusian population and is ethnospecific.

Correction of drug therapy based on genetic data contributed to a significant reduction in psychopathological symptoms, a decrease in hospitalization time, and an improvement in social functioning during follow-up in 80% of patients (50 patients with schizophrenia, schizotypal and delusional disorders). The average length of hospital stay per year (bed-days) in the study group decreased from 78.2 ± 13.2 to 28.9 ± 7.8 (p = 0.002 according to Wilcoxon's test). The economic effect fr om the introduction of the method was 2354.57 BYN per patient per year.
Advantages and Innovations
In comparison with analogues of pharmacogenetic tests for psychiatry Genomind (R) and GeneSight (R) (USA), the developed method is applicable for a complete list of psychotropic drugs registered in the Republic of Belarus and used for the correction and treatment of mental and behavioral disorders.
Stage of development
Already on the market
Comments regarding stage of development
The information system for the interpretation of the results of pharmacogenetic testing of patients with mental and behavioral disorders "Pharmacogenetics" has been introduced and is actively used in the practical health care of the state institution "Republican Scientific and Practical Center for Mental Health".
Funding source
State budged
Internal
IPR status
Exclusive rights
Secret know-how
Sector group
Healthcare
ICT Industry & Services

Organization information

Type
R&D institution
Year established
1974
NACE keywords
A.01.61 - Support activities for crop production
M.72.19 - Other research and experimental development on natural sciences and engineering
M.74.90 - Other professional, scientific and technical activities n.e.c.
Q.86.90 - Other human health activities
Turnover (in EUR)
10-20M
Already engaged in transnational cooperation
Yes
Additional comments
A significant amount of fundamental research is carried out under the grants of the Belarusian Republican Foundation for Basic Research, including with the participation of international partners - organizations from Russia, the Czech Republic, etc.
Languages spoken
English
Russian

Information about partnership

Type of partnership considered
Distribution services agreement
Outsourcing agreement
Type and role of partner sought
Consumers of the method of personalizing drug treatment in psychiatry using the results of pharmacogenetic testing under an outsourcing agreement.
Partners for the conclusion of an agreement on distribution services.
Type and size of partner sought
> 500
251-500
SME 51-250
SME 11-50
SME <= 10
R&D Institution

Attachments

Views: 1718
Statistics since 23.05.2021 10:48:33